Overseas Regulatory Announcement-Announcement on Peramivir Injection Having Obtained the Notification of Approval of Supplementary Drug Application

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

Final Dividend for the Year Ended 31 December 2023

Proposed Amendments to the Articles of Association

Proposed Change of Auditors

Announcement Notice of Board Meeting

Overseas Regulatory Announcement-Announcement on Ibuprofen Sustained Release Capsules Obtaining the Drug Registration Certificate

Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

Announcement on Prednisone Having Obtained the Notification of Approval of Application for Marketing of Active Pharmaceutical Ingredient

Notification Letter and Reply Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications